Tutkijat / Oulu  | Ala-Kokko, L. |
| Ala-Kokko, T(ero) |
| Ala-Korpela, M(ika) |
| Alahuhta, S. |
| Alen, M. |
| Antikainen, R. |
| Anttonen, V(uokko) |
| Biancari, F(austo) |
| Bloigu, R(isto) |
| Eskelinen, S. |
| Flinkkilä, T(apio) |
| Hakkola, J. |
| Hallman, M. |
| Hartikainen, A(nna)-L(iisa) |
| Hausen, H. |
| Hautala, N(ina) |
| Hautala, T(imo) |
| Heape, A. |
| Herzig, K(arl)-H(einz) |
| Hillbom, M. |
| Hiltunen, J.K. |
| Hörkko, S. |
| Huikuri, H(eikki) |
| Hukkanen J(anne) |
| Ignatius, J. |
| Isohanni, M. |
| Jaakkola, J. |
| Jaakkola, M(aritta) S. |
| Jaakola, V-P. |
| Jämsä, T(imo) |
| Janhonen, S. |
| Järvelin, M(arjo)-R(iitta) |
| Jokelainen, J(ari) |
| Juffer, A.H. |
| Junttila, J(uhani) |
| Juvonen, T. |
| Kaarteenaho, R(iitta) |
| Kajantie, E(ero)*(THL/OY) |
| Karppinen (Koivunen), P(eppi) |
| Karppinen, J(aro) |
| Karttunen, T.J. |
| Keinänen-Kiukaanniemi, S(irkka) |
| Kerkelä, R(isto) |
| Kesäniemi, Y.A. |
| Kettunen, J(ohannes) |
| Kietzmann, T(homas). |
| Kivirikko, K.I. |
| Knuuttila, M. |
| Koivukangas, J. |
| Kursula, P. |
| Kyngäs, H. |
| Larivaara, P. |
| Larmas, M. |
| Lehenkari, P(etri) |
| Lehtiö, L(ari) |
| Leppilahti, J. |
| Luukinen, H. |
| Mainio A |
| Majamaa, K. |
| Mäki, P(irjo) |
| Mäkikallio, T(imo) H. |
| Männikkö, M(inna) |
| Manninen, A(ki). |
| Martikainen, H(annu) |
| Miettunen, J(ouko) |
| Myllyharju, J. |
| Myllylä, R. |
| Myllylä, V. |
| Näyhä, S. |
| Neubauer, P. |
| Nieminen, M(iika) T. |
| Nieminen, P(entti) |
| Niinimäki, J(aakko) |
| Ohukainen, P(auli) |
| Oikarinen, A. |
| Oikarinen, K. |
| Pelkonen, O(lavi) |
| Petäjä-Repo, U.E. |
| Pihlajaniemi, T. |
| Pirttiniemi, P(ertti) |
| Puistola, U(lla) |
| Rajaniemi, H.J. |
| Rämet, M(ika) |
| Räsänen, P. |
| Raustia, A. |
| Remes, A(nne) |
| Risteli, J. |
| Ristiniemi, J. |
| Ruddock, L.W. |
| Ruokonen, A. |
| Ruskoaho, H. |
| Ryynänen, M. |
| Saarakkala, S. |
| Saari, A. |
| Salo, T(uula) |
| Sándor, G(eorge) K. |
| Savolainen, E-R. |
| Savolainen, M.J. |
| Savolainen, O. |
| Sillanpää, M(ikko). |
| Soininen, R. |
| Sorri, M. |
| Taanila, A. |
| Tapiainen, T(erhi) |
| Tervonen, O(smo) |
| Timonen, M(arkku) |
| Tjäderhane, L. |
| Turpeenniemi-Hujanen, T. |
| Tuukkanen, J(uha) |
| Tuulonen, A. |
| Uhari, M. |
| Ukkola, O(lavi) |
| Uusimaa, J. |
| Vainio, O. |
| Vainio, S. |
| Väyrynen, J(uha) P. |
| Veijola, J(uha) |
| Veijola, R(iitta) |
| Virokannas, H. |
| Voipio, H(anna)-M(arja) |
| Vuolteenaho, O. |
| Weckström, M. |
| Wei, GH. |
| Wierenga, R.K. |
| Winqvist, R(obert) |
| Ylänne, J. |
| Ylitalo, K(ari) |
Scholar Chart >>
|
»My Articles
»Latest Feeds
»Popular Feeds
|
| | Bronchoalveolar lavage differential cell count on prognostic assessment of patients with stable or acute interstitial lung disease: A retrospective real-life study. | Kaarteenaho, R(iitta) | 3 days | save |  |  |  | |
| The challenges in classifying rheumatoid arthritis-associated interstitial lung disease. | Kaarteenaho, R(iitta) | 70 days | save | | | | |
| Prognosis and causes of death of patients with acute exacerbation of fibrosing interstitial lung diseases. | Kaarteenaho, R(iitta) | 162 days | save | | | | |
| 'Compositional data analysis' by Barabesi and Sartorelli: Authors' response. | Kaarteenaho, R(iitta) | 198 days | save | | | | |
| A Family With A20 Haploinsufficiency Presenting With Novel Clinical Manifestations and Challenges for Treatment. | Kaarteenaho, R(iitta) | 237 days | save | | | | |
| Comparison of disease progression subgroups in idiopathic pulmonary fibrosis. | Kaarteenaho, R(iitta) | 292 days | save | | | | |
| Lats1 and Lats2 are required for the maintenance of multipotency in the Müllerian duct mesenchyme. | Kaarteenaho, R(iitta) | 351 days | save | | | | |
| Bronchoalveolar cell differential count and the number of asbestos bodies correlate with survival in patients with asbestosis. | Kaarteenaho, R(iitta) | 421 days | save | | | | |
| Demographics and survival of patients with idiopathic pulmonary fibrosis in the FinnishIPF registry. | Kaarteenaho, R(iitta) | 430 days | save | | | | |
| Inorganic particulate matter in the lung tissue of idiopathic pulmonary fibrosis patients reflects population density and fine particle levels. | Kaarteenaho, R(iitta) | 494 days | save | | | | |
| Cadherin-11-mediated adhesion of macrophages to myofibroblasts establishes a profibrotic niche of active TGF-β. | Kaarteenaho, R(iitta) | 610 days | save | | | | |
| Haploinsufficiency of A20 impairs protein-protein interactome and leads into caspase-8-dependent enhancement of NLRP3 inflammasome activation. | Kaarteenaho, R(iitta) | 680 days | save | | | | |
| Biallelic mutations in human NHLRC2 enhance myofibroblast differentiation in FINCA disease. | Kaarteenaho, R(iitta) | 727 days | save | | | | |
| Delay and inequalities in the treatment of idiopathic pulmonary fibrosis: the case of two Nordic countries. | Kaarteenaho, R(iitta) | 849 days | save | | | | |
| The neutrophil-mobilizing cytokine interleukin-26 in the airways of long-term tobacco smokers. | Kaarteenaho, R(iitta) | 850 days | save | | | | |
| Underlying and immediate causes of death in patients with idiopathic pulmonary fibrosis. | Kaarteenaho, R(iitta) | 859 days | save | | | | |
| Analysis of the Histologic Features Associated With Interobserver Variation in Idiopathic Pulmonary Fibrosis. | Kaarteenaho, R(iitta) | 947 days | save | | | | |
| NHLRC2 variants identified in patients with fibrosis, neurodegeneration, and cerebral angiomatosis (FINCA): characterisation of a novel cerebropulmonary disease. | Kaarteenaho, R(iitta) | 951 days | save | | | | |
| Several high-resolution computed tomography findings associate with survival and clinical features in rheumatoid arthritis-associated interstitial lung disease. | Kaarteenaho, R(iitta) | 953 days | save | | | | |
| Interleukin-26 Production in Human Primary Bronchial Epithelial Cells in Response to Viral Stimulation: Modulation by Th17 cytokines. | Kaarteenaho, R(iitta) | 1114 days | save | | | | |
| Effect of smoking and comorbidities on survival in idiopathic pulmonary fibrosis. | Kaarteenaho, R(iitta) | 1121 days | save | | | | |
| Histological features of malignancy correlate with growth patterns and patient outcome in lung adenocarcinoma. | Kaarteenaho, R(iitta) | 1254 days | save | | | | |
| Are physicians in primary health care able to recognize pulmonary fibrosis? | Kaarteenaho, R(iitta) | 1275 days | save | | | | |
| Are risk predicting models useful for estimating survival of patients with rheumatoid arthritis-associated interstitial lung disease? | Kaarteenaho, R(iitta) | 1342 days | save | | | | |
| Gender differences in the T-cell profiles of the airways in COPD patients associated with clinical phenotypes. | Kaarteenaho, R(iitta) | 1351 days | save | | | | |
| Treatment of idiopathic pulmonary fibrosis: a position paper from a Nordic expert group. | Kaarteenaho, R(iitta) | 1400 days | save | | | | |
| Mucin-1 correlates with survival, smoking status, and growth patterns in lung adenocarcinoma. | Kaarteenaho, R(iitta) | 1508 days | save | | | | |
| Variable course of disease of rheumatoid arthritis-associated usual interstitial pneumonia compared to other subtypes. | Kaarteenaho, R(iitta) | 1514 days | save | | | | |
| Linoleic acid-derived lipid mediators increase in a female-dominated subphenotype of COPD. | Kaarteenaho, R(iitta) | 1570 days | save | | | | |
| Pirfenidone and nintedanib modulate properties of fibroblasts and myofibroblasts in idiopathic pulmonary fibrosis. | Kaarteenaho, R(iitta) | 1687 days | save | | | | |
| | 
report | | | |
|
